Moderna (MRNA) lost $24 billion in market cap Thursday after data for its cancer vaccine trial leaked. Diane King Hall says investor expectations were above what leaked results showed. Mixed earnings and lower guidance in Deckers (DECK) caused the stock to step down near 52-week lows. Diane discusses the concerns JPMorgan has with Norwegian Cruise Line by looking at its downgrade.